Literature DB >> 35814889

Vitreous function and intervention of it with vitrectomy and other modalities.

Yao Zong1, Qian-Ying Gao2, Yan-Nian Hui3.   

Abstract

The vitreous body, the largest intraocular component, plays a key role in eye development, refraction, cell barrier function, oxygen metabolism and the pathogenesis of assorted diseases. Age, refraction and systemic diseases can cause vitreous metabolic abnormalities. With the continuous development of vitrectomy techniques and equipment, vitreous injections and vitrectomies have increased over the recent decades. However, the normal oxygen tension gradient in the vitreous helps to protect the lens and anterior chamber angle from oxidative stress damage, whereas the increased vitreous oxygen tension around lens and the trabecular meshwork after vitrectomy. It may lead to postoperative nuclear cataract and increase the risk for glaucoma. As a conventional procedure, scleral buckling holds several advantages over vitrectomy in selected cases. This review raises concerns regarding the function of the vitreous and encourages conducting vitreous interventions prudently if it is possible. International Journal of Ophthalmology Press.

Entities:  

Keywords:  function; oxygen metabolism; scleral buckling; vitrectomy; vitreous

Year:  2022        PMID: 35814889      PMCID: PMC9203484          DOI: 10.18240/ijo.2022.06.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  98 in total

1.  Chandelier-Assisted External Subretinal Fluid Drainage in Primary Scleral Buckling for Treatment of Rhegmatogenous Retinal Detachment.

Authors:  Sara J Haug; J Michael Jumper; Robert N Johnson; H Richard McDonald; Arthur D Fu
Journal:  Retina       Date:  2016-01       Impact factor: 4.256

2.  Mycobacterium abscessus scleritis following intravitreous injection of bevacizumab.

Authors:  Jeffery R Golen; Edgar M Espana; Curtis E Margo
Journal:  JAMA Ophthalmol       Date:  2013-10       Impact factor: 7.389

3.  Vitreous substitutes: challenges and directions.

Authors:  Qian-Ying Gao; Yue Fu; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

4.  Progression of cataracts following photodynamic therapy combined with intravitreous triamcinolone injection in cases of age-related macular degeneration.

Authors:  Hisashi Iwami; Takeya Kohno; Manabu Yamamoto; Mayumi Kaida; Norito Miki; Shinsuke Ataka; Kunihiko Shiraki
Journal:  Osaka City Med J       Date:  2011-12

5.  Computational model for oxygen transport and consumption in human vitreous.

Authors:  Benjamen A Filas; Ying-Bo Shui; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-15       Impact factor: 4.799

Review 6.  Hyaluronan and chondroitin sulfate proteoglycans in the supramolecular organization of the mammalian vitreous body.

Authors:  Dimitrios A Theocharis; Spyros S Skandalis; Argiris V Noulas; Nickoletta Papageorgakopoulou; Achilleas D Theocharis; Nikos K Karamanos
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

7.  Choice of Primary Rhegmatogenous Retinal Detachment Repair Method in US Commercially Insured and Medicare Advantage Patients, 2003-2016.

Authors:  Mary-Grace Reeves; Suzann Pershing; Armin R Afshar
Journal:  Am J Ophthalmol       Date:  2018-08-23       Impact factor: 5.258

8.  Incidence and epidemiological characteristics of rhegmatogenous retinal detachment in Beijing, China.

Authors:  Xiaoxin Li
Journal:  Ophthalmology       Date:  2003-12       Impact factor: 12.079

9.  Timing and outcomes after silicone oil removal in proliferative vitreoretinopathy: a retrospective clinical series.

Authors:  Renata Leite De Pinho Tavares; Mário Junqueira Nóbrega; Fernando Amaral Junqueira Nóbrega; Fernando José De Novelli; Carlos Augusto Cardim De Oliveira
Journal:  Int J Retina Vitreous       Date:  2015-04-15

Review 10.  Complications Associated with the Use of Expandable Gases in Vitrectomy.

Authors:  Piotr Kanclerz; Andrzej Grzybowski
Journal:  J Ophthalmol       Date:  2018-11-18       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.